Region Gotland
- Address
- S:t Goransgatan 5, Visby Domkyrkofors., 621 55 Visby, Sweden
Region Gotland - Clinical Research Center
Region Gotland is a clinical research center actively contributing to evidence-based medicine through participation in diverse therapeutic studies. The center's research portfolio encompasses metabolic disorders, renal diseases, infectious diseases, preventive oncology, and cardiovascular conditions, demonstrating a commitment to addressing both chronic disease management and public health challenges.
- Diabetes management: Comparing SGLT2 inhibitors to metformin as first-line therapy in early type 2 diabetes
- Infectious disease: Evaluating alternative oral antibiotic regimens for multidrug-resistant urinary tract infections caused by ESBL-producing bacteria
- Preventive oncology: Investigating concomitant HPV vaccination and screening strategies for cervical cancer elimination
- Heart failure therapeutics: Assessing mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction
The center participates in innovative trial designs including registry-based randomized controlled trials and contributes to national public health initiatives through organized screening programs. Research areas include rare renal conditions such as C3 glomerulopathy, where novel complement inhibition strategies are being evaluated. Region Gotland's involvement in pragmatic clinical trials reflects a commitment to generating real-world evidence that directly impacts clinical practice and patient outcomes in Sweden.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 26 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Region Skane1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Region Skane2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Region Gotland
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized Controlled Trial Comparing Dapagliflozin Propanediol and Metformin in Early Stage Type 2 Diabetes for Mortality and Vascular Complications | Uppsala University | Phase III | Recruiting | Aug 2024 | — |
IMP list
lock Showing 1 of 26 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aliskiren | 1 | Unknown | 2020-01-01 | 2020-01-01 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.